FDA Approved: GONAL-F RFF REDI-JECT — Supplemental Application (EMD Serono, Inc.)

View source ↗

Summary

FDA approved a supplemental application for GONAL-F RFF REDI-JECT (follitropin) related to its REDI-JECT delivery system, expanding the approved formulation/dev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Infertility
• Ovulatory Dysfunction

Drugs mentioned

• GONAL-F RFF REDI-JECT (Follitropin)

Snippet

SUPPL AP for GONAL-F RFF REDI-JECT (FOLLITROPIN)